课题基金 / 基金详情

The elucidation of the early immune system in percutaneous infection of HSV and HIV and the development of novel methods to prevent their cutaneous infection

The elucidation of the early immune system in percutaneous infection of HSV and HIV and the development of novel methods to prevent their cutaneous infection
阐明 HSV 和 HIV 经皮感染的早期免疫系统并开发预防其皮肤感染的新方法
批准号:
23390282
负责人:
SHIMADA Shinji
金额:
$12.48万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011-04-01 至 2014-03-31

项目摘要

项目成果

SHIMADA Shinji的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
HSV-2 shedding is associated with increased risk for sexually acquiring HIV. Because Langerhans cells (LCs) are suspected to be the initial target cells infected by HIV following sexual exposure, we studied whether HSV-2 affects HIV infection of LCs. HSV-2 enhanced HIV susceptibility in LCs within skin explants, even though relatively few HSV-2/HIV co-infected LCs were detected, suggesting that HSV-2 enhances HIV infection of LCs through indirect mechanisms. Indeed, HSV-2 stimulated production of antimicrobial peptides (AMPs) by epithelial cells, including human defensins and LL-37, and the latter strongly enhanced HIV susceptibility in LCs by up-regulating HIV receptors. Culture supernatants of epithelial cells infected with HSV-2 enhanced HIV susceptibility in LCs, and this effect was abrogated by blocking LL-37 production. These data suggest that HSV-2 enhances sexual transmission of HIV by increasing HIV susceptibility of LCs via epithelial cell production of LL-37.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Gutter method : noninvasive management of ingrown nails caused by epidermal growth factor inhibitor treatment
Gutter法:表皮生长因子抑制剂治疗引起的指甲内嵌的无创治疗
DOI: --
发表时间: 2012
期刊: Clin Exp Dermatol
影响因子: 4.1
作者: [Harada K, Yamaguchi M, Miyajima S, Kawamura T, Shibagaki S, Shimada S]
通讯作者: Shimada S
Antimicrobial Peptide LL-37 Produced by HSV-2-Infected Keratinocytes Enhances HIV Infection of
HSV-2 感染的角质形成细胞产生的抗菌肽 LL-37 可增强 HIV 感染
DOI: --
发表时间: 2013
期刊: Cell Host & Microbe
影响因子: 30.3
作者: [小川陽一, 川村龍吉, 松澤高光, 青木類, Peter Gee, 山下篤哉, 森石恆司, 山崎研志, 小柳義夫, Andrew Blauvelt, 島田眞路]
通讯作者: 島田眞路
皮膚科学講座 - 山梨大学 医学部
皮肤科课程 - 山梨大学医学部
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Two cases of autosomal recessive woolly hair with LIPH gene mutations
常染色体隐性羊毛状毛发LIPH基因突变2例
DOI: 10.1111/j.1365-4632.2012.05775.x
发表时间: 2013
期刊: Int J Dermatol
影响因子: 3.6
作者: [Harada K, Inozume T, Kawamura T, Shibagaki N, Kinoshita T, Deguchi N, Shimada S]
通讯作者: Shimada S
10
    The alarmin IL-33 derived from HSV-2-infected keratinocytes triggers mast cell-mediated antiviral innate immunity
    • 批准号:
      26293256
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.65万
    • 财政年份:
      2014
    • 负责人:
      SHIMADA Shinji
    • 依托单位:
    Development of an innovative, simple system to detect the critical gene mutations of skin cancers
    • 批准号:
      26670522
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2014
    • 负责人:
      SHIMADA Shinji
    • 依托单位:
    Examination of the participation in HIV infection of the VitaminD3 and HSV-2 using the humanized mouse
    • 批准号:
      23659545
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2011
    • 负责人:
      SHIMADA Shinji
    • 依托单位:
    Novel therapeutic approach to melanoma-bearing hosts with protein-transduction technology
    • 批准号:
      20390306
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.06万
    • 财政年份:
      2008
    • 负责人:
      SHIMADA Shinji
    • 依托单位:
    国内基金
    海外基金
    人类免疫缺陷病毒(HIV)总核酸检测试剂盒
    HIV相关肺癌免疫微环境中关键免疫细胞亚群的功能特征与调控机制研究
    基于深度测序与SNV 芯片的HIV重复感染与毒株重组机制研究
    • 批准号:
      2026JJ81281
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      徐艳
    • 依托单位:
    PGT123中和抗体修饰的工程化载肽囊泡疫苗通过诱导CD4+ T细胞极化在抗HIV感染中的应用和机制研究